news
FDA approves AbbVie’s Mavyret for hepatitis C
The FDA has approved Mavyret to treat adults with chronic hepatitis C virus genotypes 1-6 without cirrhosis or with mild cirrhosis...
List view / Grid view
Formulation
news
New injectable antiretroviral treatment for HIV patients
A phase II clinical trial has paved the way to the implantation of all-injectable antiretroviral therapies with a lower frequency of administration...
news
Artificial intelligence for human age-reversal
Insilico Medicine develops the advanced artificial intelligence algorithms to study the ageing processes and discover new interventions in ageing...
news
Uncovering the cause of immunotherapy resistance in tumours
Scientists have uncovered a key factor in the development of immunotherapy resistance in the case of cutaneous melanoma. This could potentially lead to future improvements in cancer therapy.
news
Double network hydrogels make drug-releasing systems safer
Double network hydrogel composed of two interwoven polymer nets to improve the safety of drug-delivery systems that reside within the stomach...
news
US ophthalmic drugs market set to pass $34bn by 2025
Major market players across the US are upping investments in research to innovate on treatment methods and improve ophthalmic drugs action...
news
Oramed appoints Dr Simon Bruce as Vice President of Medical Affairs
Oramed announced today the appointment of Dr Simon Bruce MD to the newly created position of Vice President of Medical Affairs...
article
Freeze-dried formulations: a new perspective on reformulating naloxone
Opioid overdose in the US and in Europe is on the rise, and the role of prescription-sourced drugs such as oxycodone cannot be underestimated...
article
Raman Spectroscopy In-Depth Focus
In this Raman Spectroscopy In-Depth Focus: Subvisible particle identification in protein-based formulations by Raman spectroscopy; Raman spectroscopy as a blood glucose monitoring tool...
article
Subvisible particle identification in protein-based formulations by Raman spectroscopy
Subvisible particles in protein-based formulations can have different origins. Particles can be extrinsic (unexpected foreign material), intrinsic (from the production environment or primary packaging), and inherent (from the formulation). It is important that inherent particles (protein agglomerates) are distinguished from the other two types and that the extrinsic and intrinsic…
article
Formulation Development & Delivery In-Depth Focus
In this Formulation Development & Delivery In-Depth Focus: A report on the use of freeze-drying to develop orally disintegrating tablets; a review of mucosal drug delivery; an interview on drug delivery through the skin; and a profile of three analytical technologies used to develop drug delivery systems...
article
Scientific Poster Gallery 2017
In this supplement, we've brought together a collection of interesting posters from leading companies in order to celebrate cutting-edge research in the pharmaceutical industry and to share with our readers some of the varied work being carried out by their colleagues...
article
Issue #3 2017 – Digital version
In Issue #3 2017: In-Depth Focuses covering Raman Spectroscopy, Separations & Purifications, Formulation Development & Delivery; Guide To Testing Services; GMP and mutual recognition; Regulatory Insight; RMMs; Microbiology Series; and much more...
news
FDA approves cryopreserved formulation of ReNeuron’s candidate
The FDA has approved the cryopreserved formulation of ReNeuron’s human retinal progenitor cell (hRPC) therapeutic candidate...
article
Shire on Haemophilia: How to treat a bleeding disorder
We caught up with Naghmana Bajwa, MD, Global Medical Affairs Haematology Lead at Shire to find out the latest in haemophilia disease research...
